Review of all the potential prodromal markers of PD phenoconversion in GBA1 and LRRK2 variant carriers leads us to the conclusion that at present no single clinical, biochemical, or imaging feature, or combination thereof can either identify those most likely to convert or when. Here, GBA1 is linked to Parkinson disease.